(HealthDay News) — Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase, according to a ...

(HealthDay News) — Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in postmenopausal women, according to a study presented at the ...

Study participants were randomly assigned 2:1 to receive once-weekly subcutaneous semaglutide 2.4mg or placebo alongside standard of care. The primary endpoints for part 1 were resolution of ...

The new report, published in the Oct. 31 issue of the US Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, states that the first US case of sexually transmitted TMVII ...

Although not bound to the committee’s recommendations, the FDA does take them into consideration when making decisions on approval. A regulatory decision is expected on December 20, 2024. If approved, ...

A health app may be linked to a patient's medical record, but that doesn’t necessarily mean that HIPAA protects the information on that health app.

For patients hospitalized with influenza, prevalence of at least one underlying medical condition increased with age.

Fluid retention occurred in 11.2% in the atrasentan group and in 8.2% in the placebo group but did not lead to discontinuation of the trial regimen.

Subcutaneous semaglutide is currently marketed under the brand name Wegovy for chronic weight management and to reduce the risk of major adverse cardiovascular events in adults with established ...

Individuals who purchased the products should contact their health care providers as abruptly stopping use may result in adverse reactions.

HealthDay News — Among privately insured patients, there was a doubling in the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as antiobesity treatment from 2022 to 2023, with a ...

Inhaled corticosteroid with short-acting β agonists or long-acting β agonist formoterol linked to reduction in exacerbations, improved control ...